Bioadaptives (BDPT) Convertible Debt (2018 - 2026)

Bioadaptives has disclosed Convertible Debt across 8 years of filings, most recently posting $424211.0 for Q1 2026.

• Convertible Debt for Q1 2026 came in at $424211.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $424211.0 (changed N/A YoY), and the FY2023 annual result was $321658.0, down 15.75% from the prior year.
• Convertible Debt came in at $424211.0 for Q1 2026 at Bioadaptives, up from $311000.0 in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $440014.0 in Q2 2022 to a low of $311000.0 in Q2 2024.
• The 4-year median for Convertible Debt is $336503.5 (2023), against an average of $360801.8.
• Across the five-year window, Convertible Debt increased 4.16% in 2022 and dropped 28.24% in 2023, its largest moves.
• Bioadaptives' Convertible Debt stood at $381793.0 in 2022, then retreated by 15.75% to $321658.0 in 2023, then slipped by 3.31% to $311000.0 in 2024, then surged by 36.4% to $424211.0 in 2026.
• The last three Convertible Debt figures came in at $424211.0 (Q1 2026), $311000.0 (Q3 2024), and $311000.0 (Q2 2024), per Business Quant data.